Despite the significance of the approval, Sage and Biogen had sought a much larger slice of the depression market, but this will have to wait as the FDA rejected zuranolone for the treatment of major depressive disorder (MDD)
Highlights Specifications 4.0 Based on 1 ratings saif-ul-allah Ali price thori kam Karyn or customer ko pasnd aya
If you, like many people, have struggled with your weight, medical weight loss can be the key to improving your confidence and getting you in shape
Punchline: With decades of research and a multi-billion-dollar gray market in motion, the peptide revolution is already here
CVS does not price-match competing pharmacies on prescription drugs
Why this trial matters : First effective gene therapy for EB Meaningfully improves quality of life and patient outcomes Drug Approvals as a Signal: 2025 Showed Real Late-Stage Productivity The FDAs 2025 novel drug approvals, alongside pivotal trialdriven cancer approvals, point to real late-stage productivity rather than incremental gains
